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Abstract The widely studied SH-SY5Y human neuroblas-
toma cell line provides a classic example of how a cancer
cell line can be instrumental for discoveries of broad bio-
logical and clinical significance. An important feature of the
SH-SY5Y cells is their ability to differentiate into a func-
tionally mature neuronal phenotype. This property has con-
ferred them the potential to be used as an in vitro model for
studies of neurodegenerative and neurodevelopmental dis-
orders. Here, we present a comprehensive assessment of the
SH-SY5Y cytogenomic profile. Our results advocate for
molecular cytogenetic data to inform the use of cancer cell
lines in research.
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Introduction
Cancer cell lines are extensively used as models to investi-
gate the genetics and behaviour of specific tumours. More
generally, they are an important resource for basic research
on diverse aspects of cellular biology, differentiation and
pathology. The widely studied SH-SY5Y human neuroblas-
toma cell line provides a classic example of how a cancer
cell line can be instrumental for discoveries of broad bio-
logical and medical significance.
Neuroblastoma is a paediatric malignancy of neuroecto-
dermal origin, characterised by genetic heterogeneity and
variable clinical progression. The SH-SY5Y cell line is a
third successive sub-clone of the SK-N-SH line, originally
established from a bone marrow biopsy of a metastatic
neuroblastoma patient [1]. The SK-N-SH parental line com-
prises at least two morphologically and biochemically dis-
tinct phenotypes: neuroblastic (N-type), that led to the sub-
cloning of SH-SY5Y (neuroblast-like), and substrate adher-
ent, non-neuronal form (S-type), that led to the sub-cloning
of SH-EP (epithelial-like). Different theories have been pos-
tulated with regard to the possible biological phenomenon
behind the co-existence of those two different cellular phe-
notypes. Trans-differentiation or the ability of neuroblasto-
ma cells to interconvert bi-directionally, in vitro, from a
neuroblast (N) to a non-neuronal (S) form was the initial
explanation [2]. Later, “clonal expansion”, or the ability of
one of the clones co-existing in the parental cell line to
expand over the other, was advanced as an alternative ex-
planation [3].
Unquestionably, the most important characteristic of the
SH-SY5Y cells is their ability to differentiate into a func-
tionally mature neuronal phenotype in the presence of var-
ious agents, for example sequential exposure to retinoic acid
and brain-derived neurotrophic factor in serum-free medium
[4], and when cultured three-dimensionally [5]. Upon dif-
ferentiation, they stop proliferating and a constant cell num-
ber is subsequently maintained.
This property has conferred the SH-SY5Y cell line with
the potential to provide an alternative to the experimental
limitations caused by the inability of primary neurons to
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propagate in vitro. Consequently, the SH-SY5Y cell line has
been extensively used as a neuronal model since the early
1980s in experimental neurological studies, including anal-
ysis of neuronal function, growth and damage in response to
insult, degeneration and differentiation.
Differentiated and undifferentiated SH-SY5Y cells have
become a popular in vitro cell model for Parkinson disease
as they possess many characteristics of dopaminergic neu-
rons [6–9]. Because upon differentiation the SH-SY5Y cells
have been found to express mature tau isoforms, this cell
line has also gained a status as an in vitro model for research
into Alzheimer’s disease [10]. The repertoire of biological
research that relies on the use of the SH-SY5Y cells has
been rapidly expanding and has recently included investi-
gations on autism-spectrum neurodevelopmental disorders
[11, 12], studies of mitochondrial metabolism and antioxi-
dant defences upon neuronal differentiation [13] and re-
search of productive varicella-zoster virus infection of
neuronal cells [14].
Neuroblastoma, like most human cancers, is character-
ised by non-random chromosomal abnormalities, to include
large-scale chromosomal imbalances, with diagnostic and
prognostic significance [15–19]. The first cytogenetic anal-
ysis of the SH-SY5Y cell line was performed by Spengler
and collaborators in 1983 [2] and a revised G-banded kar-
yotype subsequently published by the same authors in 2002
[20]. Those first classical cytogenetic studies succeeded in
describing with certain accuracy some, but obviously not
all, of the chromosomal abnormalities that were subsequent-
ly to be identified in the SH-SY5Y cell line by means of
higher-resolution molecular cytogenetic techniques. In
2001, Van Roy and collaborators published a detailed de-
scription of genetic alterations in 16 neuroblastoma cell
lines, to include the SH-SY5Y parental cell line SK-N-SH
[21]. In 2003, by applying fluorescence in situ hybridization
(FISH) with gene- and chromosome-specific probes, to in-
clude a SKY multi-colour labelling kit for spectral karyotyp-
ing, Cohen and collaborators [3] published a comparative
cytogenetic analysis of the parental SK-N-SH cell line and
SH-EP and SH-SY5Y, highlighting karyotypic similarities
and differences between the three lines. Further molecular
cytogenetic insights specifically into the karyotype of the
SH-SY5Y cell line were gained by Do and collaborators
[22] by means of comparative genomic hybridization on a
custom-designed 4000 bacterial artificial chromosomes
microarray, covering the whole human genome. That study
allowed the identification of unbalanced chromosomal
changes—gains and losses—at a resolution of 1 Mb. More
recently, Kryh and collaborators [23] published the first
high-density single-nucleotide polymorphism (SNP) array
study on the SH-SY5Y, revealing the presence of previous-
ly undetected allelic imbalances and copy-neutral loss of
heterozygosity (LOH).
In the present study, by means of a comprehensive mo-
lecular cytogenetic approach, including single-probe FISH,
multi-colour karyotyping by M-FISH and MCM-banding,
and microarray analysis for copy number variants (CNV)
and LOH, we carried out a detailed re-assessment of the
chromosomal complement and genomic profile of the SH-
SY5Y. Given the common use of this neuroblastoma cell
line as an in vitro model for studies of neurodegenerative
and neurodevelopmental disorders, our aims were to resolve
previous inconsistencies and provide the definitive SH-
SY5Y karyotype description.
Materials and methods
The SH-SY5Y cell line was purchased from the European
Collection of Cell Cultures, a Health Protection Agency
Culture Collection. Chromosome preparations were
obtained from unsynchronised cultures of early passage
cells upon receipt from the repository following standard
procedures.
Karyotyping by multiplex fluorescence in situ hybridiza-
tion (M-FISH) was performed as recommended by the
24XCyte mFISH probe kit manufacturer (MetaSystems,
Germany, http://www.metasystems-international.com). Di-
rectly labelled chromosome-specific probes used for valida-
t ion FISH experiments were: Aquarius® Whole
Chromosome Painting Probes for chromosome 17 (FITC)
and chromosome 15 (Texas Red) (Cytocell), Poseidon™
Whole Chromosome 22 Probe (blue, Platinum Bright 415)
(Kreatech), classical 1qh satellite (FITC) and classical D9Z3
satellite (Rhodamine) (Qbiogene). FISH and M-FISH
experiments were analysed on a CytoVysion system
(Genetix, UK, http://www.genetix.com), consisting of an
Olympus BX-51 epifluorescence microscope coupled to a
JAI CVM4+ CCD camera.
Multi-colour mBand FISH imaging (MCM-banding) and
analysis were performed as recommended by the XCyte1
mBand probe kit manufacturer (MetaSystems, Germany,
http://www.metasystems-international.com), utilizing a Carl
Zeiss AxioImager.Z2 epifluorescence microscope coupled
to a MetaSystems CoolCube camera and MetaSystems ISIS
software.
Analysis of copy number (CN) changes and LOH was
performed on Affymetrix Cytogenetics Whole-Genome
2.7 M Arrays. Genomic DNA from the SH-SY5Y cell line
was extracted from unsynchronysed cultures of early pas-
sage number cells upon receipt from the repository (and in
parallel with chromosome preparations) using a Qiagen
Blood & Cell Culture DNA kit. After ethanol precipitation,
the DNA was resuspended in TE buffer (10 mM Tris, pH
8.0, 1 mM EDTA) at a final concentration of 33 ng/μL.
Whole genome amplification, fragmentation and labelling
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were performed following the array manufacturer instruc-
tions. Briefly, after incubation at 50 °C in a GeneChip
Hybridization oven with rotation at 60 rpm for 19 h, the
arrays were stained in the Gene Chip Fluidic Station 450
and scanned with Affymetrix Gene Chip Scanner 3000. For
data analysis, the CEL files were imported into Chromo-
some Analysis Suite software v.1.2.2. Array quality was
evaluated as per manufacturer’s instructions and only arrays
with SNP-QC>1.1 and MAPD<0.27 were accepted for
further data analysis. The analysis was based on the assem-
bly hg19 of the human genome. Parameters were set at
minimum filter values of 60Kb, 35 marker count and 0.85
confidence for both gains and losses, and minimum filter
values of 100 Kb and 35 marker count for mosaicism. All
copy number changes observed were compared to CNVs
catalogued in the Database of Genomic Variants (DGV)
(http://projects.tcag.ca/variation/) and the UCSC genome
browser (http://genome.ucsc.edu/).
Results and discussion
We have applied an all-inclusive cytogenomic approach to
re-evaluate the karyotypic profile of the SH-SY5Y, a
neuroblastoma cell line widely used as an in vitro neuronal
model. By combining FISH-based techniques, which retain
information on a per cell basis, with high-resolution
microarray-based techniques, we were able to report thus
far unnoticed karyotypic features of the SH-SY5Y cell line.
Our findings are summarised in Table 1 together with find-
ings from previous investigations.
M-FISH analysis confirmed the presence of a set of
previously reported chromosomal abnormalities that in com-
bination define the cytogenetic identity of the SH-SY5Y cell
line (Fig. 1), consisting of chromosome 7 trisomy, a dupli-
cation of the entire q arm of chromosome 1, a balanced
translocation involving chromosomes 7 and 8, a derivative 9
t(2;9), and a derivative 22 believed to be the result a of a t
(17;22). Another distinctive karyotypic trait of the SH-
SY5Y is the lack of amplification of the N-myc proto-
oncogene.
In our study, the derivative chromosome 9, resulting from
a translocation of extra chromosome 2p material to chromo-
some 9, appeared in only 50 % of metaphases analysed by
M-FISH and dual-colour FISH analysis with chromosome-
specific probes (data not shown). This observation ties with
the mosaic status of the detected imbalance (gain) on the
short arm of chromosome 2 (2p25.3-2p16.3), as shown by
Fig. 1 Representative example of M-FISH analysis. The karyotypic identity of the SH-SY5Y cell line is confirmed by multi-colour karyotyping
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our CNV microarray data (Table 2). A high incidence of
unbalanced “jumping” translocations involving a gain of
chromosome 2 short arm material with a minimum region
of overlap 2pter-2p22 and various partner chromosomes had
been previously observed in a panel of 18 neuroblastoma
cell lines, including the parental SK-N-SH [21, 24]. Recent
SNP array studies had indicated the gain on chromosome 2p
to be an aberration shared by the SK-N-SH parental line and
its neuroblast-like sub-clone SH-SY5Y, but not its epithelial
sub-clone SH-EP [23]. Given that the three cell lines were
found in general to be very similar, sharing many of the
chromosome aberrations, it could be argued that most of the
chromosomal alterations seen in the daughter cell lines were
present in a mosaic form in the parental cell line (and
perhaps also in the original tumour), and that the karyotypes
of the daughter cell lines are the result of the combined
effect of the initial sub-cloning and subsequent cell line
evolution over time.
An intriguing finding emerging from our investigations
was the nature of the rearrangement(s) involving chromo-
some 17 and 22, which were revealed to be more complex
than previously reported. Structural abnormalities of chro-
mosome 17 resulting in gain of material are the most fre-
quent genetic abnormalities in neuroblastoma and powerful
independent predictor of poor outcome, commonly found in
primary tumours and cell lines. Our SNP array analysis
















































































































































































































































































































































































































































































































































































































































































Fig. 2 Three-colour FISH shows a complex rearrangement involving
chromosomes 15, 17 and 22. Three-colour FISH with directly labelled
chromosome-specific “paints” for chromosome 15 (red), 17 (green)
and 22 (blue) on reverse-DAPI banded chromosomes confirms the
presence of a der(22)t(15;22) (top arrow) and a der(15)t(15;17;22)
(bottom arrow)
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17q (17q21.33-17q25.3) and two distinct losses on chromo-
some 22q (22q12.3 and 22q13.1-22q13.31). Differently
from what reported previously, our M-FISH and validation
FISH experiments with chromosome-specific probes
revealed the derivative 22 to be the result of a translocation
involving not chromosome 17, as initially thought, but
chromosome 15. We also identified a der(15)t(15; 17; 22)
(Figs. 1 and 2).
The Affymetrix Cytogenetics Whole-Genome 2.7 M Ar-
ray used in this study provides high-density coverage across
the genome, with 2.7 million markers, including 400,000
SNPs, spaced throughout at a median inter-marker distance
of ∼1 kb. Indeed, multiple areas of LOH and copy number
gain were identified in this analysis of the SH-SY5Y cell
line (Table 2). Although most of the gains and losses overlap
with polymorphic CNVs documented in the DGV, it is
nevertheless interesting that the list of genes concerned by
the imbalances includes a number of transcription factors
involved with cancer and neuronal differentiation, like
ZFHX3 on chromosome 16q, SLIT 3 on chromosome 5q
and FGFR2 on chromosome 10q. Loci of neuro-biological
interest, also mapping on structurally re-arranged chromo-
somal regions in the SH-SH5Y cell line, are the Parkinson’s-
associated LINGO2 gene on chromosome 9p, the MAPT
gene (encoding TAU) on chromosome 17q, PSEN1 gene on
14q, and the 15q11-13 chromosomal region.
Almost all of the regions of LOH resulted from copy
number loss. However, we also observed extensive copy-
neutral LOH on chromosome 14q (14q21.3-14q32.33).
LOH on the long arm of chromosome 14—with a consensus
region in 14q23-q32—has been consistently observed in
primary neuroblastomas, suggesting the deletion of this
region to be a common abnormality in these tumours [25].
UPD or LOH with neutral copy number of chromosome arm
14q was also reported in primary neuroblastoma tumours
and derivative early-passage cell lines [26].
Fig. 3 High-resolution multi-colour chromosome banding provides new clues on complex 1q rearrangement. A duplication of the entire long arm
appears to have been followed by a paracentric inversion
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Our investigations by high-resolution multi-colour chro-
mosome banding on the long arm of chromosome 1 suggest
a complex rearrangement arising from a duplication of the
entire chromosome arm—as confirmed by our SNP-array
analysis—followed by a paracentric inversion, resulting in a
der(1)(1q12→1q31::1q31→1q12::1q44→1q31::1q31→
1q44) (Fig. 3). Duplication of the juxtacentromeric hetero-
chromatic area was confirmed by FISH analysis with a D1Z1
probe for the classical satellite DNA (data not shown).
In the light of what previously published and confirmed by
us, and what newly identified by us, we would like to suggest
an updated karyotypic description for the SH-SY5Y cell line
to imply the existence of two cytogenetically related sub-
clones (stemline and sideline), as follows: 47,XX, der
(1)(1q12→1q31::1q31→1q12::1q44→1q31::1q31→
1q44), +7, der(7)t(7 ;8)(q34 ;q24.2), der(8)t(7 ;8)(q34 ;q24.2),
der(15)t(15;17;22), der(22)t(15;22)[54]/47, idem, der(9)t
(2;9)[46]. The number of cells for each sub-clone in our
sample is given in square brackets. Additional CN variation
array data are summarised in Table 2. M-FISH observations
on SH-SY5Y cells at a higher passage number (data not
shown) would suggest the sideline karyotype to become prev-
alent, with most of the metaphases analysed presenting the der
(9)t(2;9) as well as new chromosomal aberrations resulting
from the extended culture.
Given the importance acquired by the SH-SY5Y cell line
as a neuronal in vitro model, a thorough understanding of its
genetic background is of paramount importance. We believe
that information on the SH-SY5 cytogenomic profile should
be factored in when designing experimental studies based
on these cells. In particular, the interpretation of the results
should be passage number- and karyotype-informed, espe-
cially with regard to gene expression data and genome
architecture of genetic loci linked to cancer or neurological
diseases which coincidentally map to chromosomal regions
that are highly re-arranged in this cell line. For instance,
biomedical research relying on the use of the SH-SY5Y
cells for highly topical diseases like Parkinson and Alz-
heimer’s and autism-spectrum developmental disorders,
should take into account possible dosage effects or position
effects on loci like the Parkinson’s-associated LINGO2 gene
on chromosome 9p, the MAPT gene (encoding TAU) on
chromosome 17q, PSEN1 gene on 14q, and the 15q11-13
chromosomal region.
Our results demonstrate the impact of an integrated mo-
lecular cytogenetic approach on the ability to resolve com-
plex karyotypes and underline the importance for the
cytogenomic profiling of cancer cell lines to inform their
use in research.
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